Topics, Trends & Updates for October (10/9/25)
https://myemail.constantcontact.com/October-2025-TTU–Updated-Drug-Drug-Interaction-Guide–plus-PrEP-Aware-Week-2025-and-new-episodes-of-Viremic–Cases-in-HIV.html?soid=1011106347108&aid=Am4zSLNvi-k
Updated: Drug-Drug Interaction Guide: From HIV Prevention to Treatment (10/7/25)
Topics, Trends & Updates for September (9/11/25)
https://myemail.constantcontact.com/September-2025-TTU–Announcing-PrEP-Aware-Week-2025–plus-new-episodes-of-Viremic–Cases-in-HIV.html?soid=1011106347108&aid=AvgyKSCAHTY
Updated: Use of Injectable CAB/RPV LA as Replacement ART in Virally Suppressed Adults (7/23/25)
NYRx: Extencilline added as reimbursable drug (7/22/25)
http://www.hivguidelines.org/wp-content/uploads/2026/03/NYRx-Notice-to-Providers-Medicaid-Coverage-of-Extencilline-FINAL-072225.pdf
Updated: Second-Line ART After Treatment Failure or for Regimen Simplification (7/23/25)
Updated: Prevention and Treatment of Mpox (7/17/25)
Topics, Trends & Updates for July (7/10/25)
https://myemail.constantcontact.com/July-2025-TTU–New-Guideline–Twice-Yearly-Injectable-PrEP–Plus-Viremic–Cases-in-HIV-Podcast.html?soid=1011106347108&aid=9W5-4dhJjd4
New: Interim Guideline on the Use of Twice-Yearly Lenacapavir for HIV Prevention (7/2/25)
Topics, Trends & Updates for June (6/12/25)
https://myemail.constantcontact.com/June-2025-TTU–Our-Commitment-to-Inclusive-Care–Plus-Updated-Pediatric-PEP-Guideline.html?soid=1011106347108&aid=d7WjIR4KkWI
